OUTSET MEDICAL INC (OM)
US6901451079 - Common Stock
Overall OM gets a fundamental rating of 2 out of 10. We evaluated OM against 188 industry peers in the Health Care Equipment & Supplies industry. OM has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, OM is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
OM had negative earnings in the past year.
In the past year OM has reported a negative cash flow from operations.
OM had negative earnings in each of the past 5 years.
In the past 5 years OM always reported negative operating cash flow.
1.2 Ratios
OM has a worse Return On Assets (-50.61%) than 69.52% of its industry peers.
With a Return On Equity value of -232.04%, OM is not doing good in the industry: 82.89% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -50.61% | ||
| ROE | -232.04% | ||
| ROIC | N/A |
ROA(3y)-41.42%
ROA(5y)-48.12%
ROE(3y)-80.71%
ROE(5y)-99.1%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
OM has a Gross Margin of 28.23%. This is in the lower half of the industry: OM underperforms 75.40% of its industry peers.
The Profit Margin and Operating Margin are not available for OM so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 28.23% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
OM does not have a ROIC to compare to the WACC, probably because it is not profitable.
OM has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, OM has more shares outstanding
Compared to 1 year ago, OM has a worse debt to assets ratio.
2.2 Solvency
Based on the Altman-Z score of -4.78, we must say that OM is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of OM (-4.78) is worse than 69.52% of its industry peers.
OM has a Debt/Equity ratio of 2.87. This is a high value indicating a heavy dependency on external financing.
OM has a Debt to Equity ratio of 2.87. This is amonst the worse of the industry: OM underperforms 87.17% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.87 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -4.78 |
ROIC/WACCN/A
WACC6.59%
2.3 Liquidity
OM has a Current Ratio of 6.80. This indicates that OM is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of OM (6.80) is better than 82.35% of its industry peers.
OM has a Quick Ratio of 5.38. This indicates that OM is financially healthy and has no problem in meeting its short term obligations.
OM's Quick ratio of 5.38 is fine compared to the rest of the industry. OM outperforms 79.68% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 6.8 | ||
| Quick Ratio | 5.38 |
3. Growth
3.1 Past
OM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 40.06%, which is quite impressive.
Looking at the last year, OM shows a quite strong growth in Revenue. The Revenue has grown by 12.98% in the last year.
OM shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 130.59% yearly.
EPS 1Y (TTM)40.06%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%45.07%
Revenue 1Y (TTM)12.98%
Revenue growth 3Y37.73%
Revenue growth 5Y130.59%
Sales Q2Q%-5.57%
3.2 Future
Based on estimates for the next years, OM will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.21% on average per year.
Based on estimates for the next years, OM will show a quite strong growth in Revenue. The Revenue will grow by 16.99% on average per year.
EPS Next Y38.7%
EPS Next 2Y25.31%
EPS Next 3Y17.61%
EPS Next 5Y15.21%
Revenue Next Year-15.28%
Revenue Next 2Y-1.69%
Revenue Next 3Y7.04%
Revenue Next 5Y16.99%
3.3 Evolution
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for OM. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for OM. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
A more expensive valuation may be justified as OM's earnings are expected to grow with 17.61% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y25.31%
EPS Next 3Y17.61%
5. Dividend
5.1 Amount
No dividends for OM!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
OUTSET MEDICAL INC
NASDAQ:OM (11/7/2024, 11:18:10 AM)
0.6981
+0.08 (+12.6%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap36.36M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -50.61% | ||
| ROE | -232.04% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 28.23% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.37
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.87 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 6.8 | ||
| Quick Ratio | 5.38 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)40.06%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y38.7%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)12.98%
Revenue growth 3Y37.73%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y